Key result
The refined deceleration capacity method demonstrated superior discrimination between end-stage renal disease patients and healthy subjects compared to the original method, achieving an AUC of 0.969 versus 0.960 for 2-hour recordings.
Why the study?
Phase-rectified signal averaging (PRSA) for cardiac vagal modulation assessment suffers from the confounding effects of anomalous variants of sinus rhythm.
Does a refined deceleration capacity (DCref) method improve the diagnostic accuracy of distinguishing ESRD patients from healthy subjects compared to the original DC method?
Observational (n=242)
Does a refined deceleration capacity (DCref) method improve the diagnostic accuracy of distinguishing ESRD patients from healthy subjects compared to the original DC method?
Answers are grounded in this paper and cite their sources.
A refined method of quantifying deceleration capacity (DCref) by excluding non-vagally mediated abnormal variants of sinus rhythm improves the assessment of cardiac vagal modulation and better distinguishes ESRD patients from healthy subjects.
Phase-rectified signal averaging (PRSA) was often applied to assess the cardiac vagal modulation. Despite its broad use, this method suffers from the confounding effects of anomalous variants of sinus rhythm. This study aimed to improve the original PRSA method in deceleration capacity (DC) quantification. The refined deceleration capacity ( DC ref ) was calculated by excluding from non-vagally mediated abnormal variants of sinus rhythms. Holter recordings from 202 healthy subjects and 51 patients with end-stage renal disease (ESRD) have been used for validity. The DC ref was compared to original DC ( DC org ) by the area under receiver operating characteristic curve. Experimental results demonstrate that the original and refined DC s calculated from 24-h, 2-h, and 30-min Holter recordings are significantly lower in patients with ESRD than those in the healthy group. In receiver operating characteristic curve analysis, the DC ref provides better performance than the DC org in distinguishing between the patients with ESRD and healthy control subjects. Furthermore, the refined PRSA technique enhances the low frequency and attenuates high frequency components for spectral analysis in ESRD patients. The DC ref appears to reduce the influence of non-vagally mediated abnormal variants of sinus rhythm and highlighting the pathological influence. DC ref , especially assessed from short-term electrocardiography recordings, may be complementary to existing autonomic function assessment, risk stratification, and efficacy prediction strategies.
No takes yet. Share an insight, caveat, or question.
Liu et al. (2018) conducted an observational in End-stage renal disease (ESRD) (n=242). Refined deceleration capacity (DCref) vs. Original deceleration capacity (DCorg) was evaluated on Discrimination between ESRD patients and healthy subjects (Area under the ROC curve for 2-hour ECG recordings). The refined deceleration capacity method demonstrated superior discrimination between end-stage renal disease patients and healthy subjects compared to the original method, achieving an AUC of 0.969 versus 0.960 for 2-hour recordings.
Synapse has enriched 10 related papers. Consider them for comparative context: